Completed NA INTERVENTIONAL 2-arm NCT01791868

Efficacy Study of Intravenous Sodium Valproate in Addition to First Line Anti Epileptic Treatment of Generalized Convulsive Status Epilepticus. (VALSE)

Randomized and Multicenter Study Assessing the Efficacy of Intravenous Sodium Valproate in Addition to First Line Anti Epileptic Treatment of Generalized Convulsive Status Epilepticus.

Sponsor: Assistance Publique - Hôpitaux de Paris

Conditions Generalized Convulsive Status Epilepticus Intensive Care Unit

Interventions Intravenous Sodium Valproate Placebo

Updated 7 times since 2017 Last updated: Oct 15, 2018 Started: Feb 28, 2013 Primary completion: Jul 31, 2018 Completion: Oct 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Generalized Convulsive Status Epilepticus and Intensive Care Unit, this trial is completed. The trial is conducted by Assistance Publique - Hôpitaux de Paris and has accumulated 7 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Nov 2018 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed
Jun 2018 — Nov 2018 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Dec 2017 — Jun 2018 [monthly]

Recruiting NA
Jan 2017 — Dec 2017 [monthly]

Recruiting NA

First recorded

Feb 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assistance Publique - Hôpitaux de Paris

Data source: Assistance Publique - Hôpitaux de Paris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Garche, France